Medpace Holdings, Inc. MEDP Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s net income?
- Medpace Holdings, Inc. (MEDP) reported net income of $123.87M in Q1 2026.
- How has Medpace Holdings, Inc.'s net income changed year-over-year?
- Medpace Holdings, Inc.'s net income increased by 8.1% year-over-year, from $114.6M to $123.87M.
- What is the long-term trend for Medpace Holdings, Inc.'s net income?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s net income has grown at a 25.5% compound annual growth rate (CAGR), from $181.85M to $451.12M.
- What does net income mean?
- The total profit a company earns after all expenses are paid.
- How do you interpret net income?
- An increase indicates higher profitability and potential for reinvestment or shareholder returns, while a decrease may signal operational challenges or margin compression.
- How does net income compare across companies?
- Standard across all public companies; peers in the CRO industry typically show consistent growth in line with clinical trial volume.